Delivery Order SPE2DR25D3301-SPE2DR26F20DP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Darzalex 100 mg/5 ml vials with a ceiling value of $1,378.59 under firm fixed price terms. The order is scheduled for completion by January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $478,416.80 to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products. This firm fixed price delivery order, awarded on September 2, 2025, represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price delivery order, valued at $149,505.25, represents a competitive award with no set-aside designation and is scheduled for completion by October 1, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, valued at $23,920.84 under a firm fixed-price contract. This delivery order, which is not set-aside, was issued on August 6, 2025, with an ultimate completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office operations...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $239,208.40, represents a competitively awarded, non-set-aside contract with a completion deadline of October 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $23,920.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with completion scheduled for December 2, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency has awarded a delivery order valued at $17,940.60 to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15mL pharmaceutical product. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by November 25, 2025. The award was issued on November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $63,022.10 for DARZALEX FASPR 1800 1S on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $17,940.63 to AmerisourceBergen Drug Corp for DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $6,747.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of DARZALEX 400 mg/20 ml vials. The contract, which is scheduled for completion by November 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location at the same address. This delivery order falls under the company's larger...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20DPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,481.75 to AmerisourceBergen Drug Corp for the supply of Darzalex 400 mg/20 ml vials. This firm fixed-price, competitively awarded delivery order was issued on January 2, 2026, with an ultimate completion date of January 26, 2026. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and runs through December 2026. This prime indefinite delivery vehicle provides comprehensive pharmaceutical support globally, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs. As one of the leading suppliers under the DLA's pharmaceutical supply chain, the company has demonstrated its capability to meet federal procurement requirements through open competition across numerous contract awards. The DLA Troop Support is currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, potentially involving at least three different contractors, signaling continued modernization of the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 1/1/26 |